Ruth Bader Ginsburg’s Impact On Pharma, From Patents To The First Amendment

 
• By Brenda Sandburg

Justice Ginsburg wrote two decisions in pharmaceutical related-cases over the past decade, joined the majority in opinions on the scope of patents, and dissented in decisions giving protection to generic manufacturers and speech of pharmaceutical companies. Her death could impact the outcome of cases challenging the Affordable Care Act.

WASHINGTON SEPTEMBER 20, 2020 – Notes and flowers are left at the Supreme Court of the United States in memory of late Supreme Court Justice Ruth Bader Ginsburg in Washington DC on September 20, 2020
Justice Ruth Bader Ginsburg's death will have impact on wide range of Supreme Court cases

More from Legal & IP

More from Pink Sheet